stopping bleeding during surgery for diabetic retinopathy

Hemostasis with Fibrin Glue in Surgery for vascular retinopathy (HEGLU) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064331

Enrollment

Registered

2024-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: H36- Retinal disorders in diseases classified elsewhere

Interventions

Intervention1: Fibrin glue: Fibrin glue is used by neurosurgeons chiefly to attain hemostasis and as dural sealants. (2) It is also commonly used in ocular surgeries by ocular surface surgeons and cor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing surgery for PDR and RVO primary or secondary

Exclusion criteria

Exclusion criteria: 1.Previous retinal surgeries 2.Retinal breaks pre-existing and iatrogenic 3.Cases where significant retinal membranes could not be removed around bleeders 4.Massive tractional retinal detachment a total area of retinal detachment exceeding 10 DD

Design outcomes

Primary

Measure	Time frame
Occurrence of any retinal bleeding in excess of final intraoperative condition.Timepoint: Day 1, 1 week, 1 month, 3 months	—

Secondary

Measure	Time frame
1.Occurrence of RVH necessitating re surgery 2.Development of significant retinal membranes. Timepoint: 1 week, 1 month, 3 momths	—

Countries

India

Contacts

Public ContactDr Ritesh Narula

LV Prasad Eye Institute

ritesh.narula@lvpei.org9711857437

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026